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Abstract

TEST OF BPA’S ESTROGENIC EFFECTS ON BRAIN AROMATASE
EXPRESSION, NEURAL ACTIVITY, AND LOCOMOTIVE BEHAVIOR IN
ZEBRAFISH LARVAE

Ryan Jordan McAuley

Bisphenol A (BPA) is a well-known endocrine disrupting chemical that mimics the
effects of estrogens. Aromatase B (Cyp19a1b) is a brain-specific enzyme that converts
testosterone to estrogen and is highly upregulated in response to estrogen receptor
activation localized to radial glial cells. During embryonic zebrafish development, there
is a small window of time denoted by an increase in neurogenesis and estrogen receptor
activity. Previous studies have demonstrated that a low dose BPA exposure (0.1µM)
during this window causes hyperlocomotion in larval zebrafish, yet no further
explanation for this behavior change has been described. The purpose of this study was
to identify whether (0.1µM) BPA exposure during this developmental window could be
influencing Ca2+ dynamics, and if this correlated to swim activity changes. Two
transgenic zebrafish lines, Cyp19a1b:GFP and Elavl3:GCaMP, were used in order to
measure changes caused by BPA exposure. Confocal microscopy imaging techniques
quantified Cyp19a1b expression in radial glia and dynamic GCaMP expression in
neurons over time but did not find significant effects between BPA-treated and controlii

treated groups for either measurement. Furthermore, swim activity tests failed to
replicate the difference in time spent swimming between BPA and control groups.
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Introduction

Endocrine disrupting chemicals (EDCs) are compounds that can mimic,
antagonize, alter or otherwise interfere with endogenous steroid production, metabolism
or action at receptor targets (Frye et al., 2012). Thousands of chemicals have been
identified as having endocrine disrupting properties and are of both naturally-occurring or
synthetic origin. They can originate from numerous sources and may enter the aquatic
environment through wastewater, agricultural run-off, and groundwater discharge,
leading to contamination of the ecosystem through bioaccumulation in plant and animal
bodies (Caballero-Gallardo, Olivero-Verbel, & Freeman, 2016). Xenoestrogens are a
class of EDC which appears to be especially persistent in the environment. They are
natural or industrial compounds that specifically mimic endogenous estrogens or interfere
with estrogen signaling pathways. Exposure through ingestion or contact can often result
in detectable effects such as estrogen activation (EA) at low concentrations, particularly
critical effects may occur during the fetal and postnatal developmental stages (Kerdivel,
Habauzit, & Pakdel, 2013).
One such xenoestrogen which has garnered the attention of researchers is
Bisphenol A (BPA). It is a high-volume production chemical present in polycarbonate
plastics and epoxy resins which are used in many common products such as
beverage/food containers, the interior lining of metal cans, and the ink for thermal paper
receipts (Frye et al., 2012). BPA has been acknowledged as a high priority for health
assessment risk due to widespread exposure in humans. 95% of American adults have
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BPA present in their urine at biologically relevant levels (Calafat et al., 2005) and
exposure is likely to occur due to it leaching from plastics at low concentrations, a
process which can often be accelerated from common stressors such as sunlight, UV &
microwave radiation, and moist heat (Yang, Yaniger, Jordan, Klein, & Bittner, 2011).
Effects of BPA exposure in humans is not yet fully understood but it appears to be
correlated with male & female infertility, precocious puberty, breast & prostate cancers,
and metabolic disorders such as polycystic ovarian syndrome (Diamanti-Kandarakis et
al., 2009).
Animal models are increasingly being used in recent years as tools further define
BPA’s actions on biological systems. Zebrafish (Danio rerio) as a model organism
displays conservation of many aspects of the endocrine system when compared to other
vertebrates, including humans (Löhr & Hammerschmidt, 2011). High reproducibility,
short generation time, ease of care, transdermal absorption of drugs, transparency during
embryonic development, and simplicity of behavioral responses are amongst the traits
which make zebrafish ideal for researchers interested in questions about development and
disease. Furthermore, the generation of transgenic zebrafish lines which express
fluorescent proteins has proven to be an invaluable tool since zebrafish embryos are
transparent during embryonic development, which makes in vivo imaging possible.
Optogenetic research with transgenic zebrafish has been able to identify ER activity in
response to both natural and synthetic estrogens by observing fluorescence in estrogenic
tissues such as the liver, ovary, pituitary gland, and brain (Gorelick & Halpern, 2011).
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Within the last 10 years, the generation of estrogenic-responsive transgenic
zebrafish lines has led to more interest and progress in research describing the many
effects of xenoestrogen exposure. Although research began by identifying effects on
sexual development, mating behaviors, and general toxicity, only recently has research
began to focus on effects directly exerted through interactions with the brain. The
development of a transgenic Cyp19a1b:GFP zebrafish line which expresses green
fluorescent protein in response to the brain aromatase Cyp19a1b promotor has become a
useful tool for direct evaluation of xenoestrogens’ EA and characterization of radial glia
in the developing brain (Tong et al., 2009). In the past few years this line has been able
to demonstrate that BPA induces fluorescence in embryos at environmentally relevant
concentrations, and that exposure leads to changes in neuronal and glial proliferation as
well as behavioral changes.
There is still much to be discovered about how these effects may be related.
Replication of these results and further experiments designed to explain mechanisms by
which the changes in neural development from BPA may lead to behavioral differences
may both reinforce recent findings while helping fill in gaps in the literature.
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Literature Review

Endocrine Disrupting Chemicals
The topic that this study wishes to investigate is the consequences of exposure to
endocrine-disrupting chemicals during early brain development. Endocrine-disrupting
chemicals (EDCs) are substances present in the environment, food, and consumer
products which are implicated in interference with hormone biosynthesis, metabolism,
homeostatic control, and reproduction (Diamanti-Kandrarakis et al., 2009).
Xenoestrogens. Xenoestrogens are a class of EDC that has been garnering
attention from researchers for their ability to imitate estrogen. They can be either
synthetic or natural molecules which have estrogenic activity (EA) when interacting with
living organisms. Many synthetic xenoestrogens are present in the environment due to
their use in a wide variety of industrial compounds. Thermoplastic resins created from
polymerizing specific monomers and additives have been demonstrated to exhibit EA due
to the physicochemical property of an insufficiently hindered phenol group which enables
binding to estrogen receptors (Yang et al., 2011). Many types of polycarbonate (PC)
plastic products are known to leach EA chemicals, and it has recently discovered that
even PC-replacement products may leach chemicals with EA whether stressed or
unstressed (Bittner, Yang, & Stoner, 2014). In mammals, chemicals which induce EA
can produce many health-related problems such as obesity, early puberty in females,
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reduced sperm counts, altered functions of reproductive organs, altered sex-specific
behaviors, and increased rates of some breast, ovarian, testicular, and prostate cancers.
Bisphenol A (BPA). Bisphenol A, a xenoestrogen, is a key monomer used in the
manufacturing of polycarbonate plastic or epoxy resins. Polycarbonate plastics are used
to make a variety of products including water bottles and food containers. BPA has been
shown to leach from these containers, especially when exposed to UV radiation,
microwave radiation, and/or moist heat from boiling or dishwashing (Yang et al., 2011).
BPA is also used as a color developer in carbonless copy paper and thermal point of sale
receipt paper, and in these is present as a non-polymerized form more readily available
for exposure (Hormann et al., 2014). BPA has been shown to be present in 94% of
thermal receipt papers at concentrations up to 13.9mg/g, and thermal receipt papers
contributed to over 98% of human exposure cases (Liao & Kannan, 2011). When BPA is
ingested it does not linger in the body for long, it is conjugated to glucuronide and
excreted by the kidneys, yet even while in BPA-G form it remains biologically active by
increasing lipid accumulation and adipogenesis (Boucher, Boudreau, Ahmed, & Atlas,
2015). Urine samples of United States adults have shown that 95% of participants had
BPA concentrations greater than 0.1μg/L, which indicates that human exposure to the
chemical is widespread (Calafat et al., 2005). BPA has been acknowledged to interact
with human estrogen receptors as an endocrine disruptor even at low doses, however its
binding to ER and hormonal activity is extremely weak relative to estradiol (Takayanagi
et al., 2006).
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Figure 1. Sources of EDCs in environmental waters and human exposure.
Figure sourced from (Caballero-Gallardo, Olivero-Verbel, & Freeman, 2016).
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Figure 2. 2D Structures of Estradiol and Bisphenol A. Chemical structure images
sourced from Baker and Hardiman (2014).
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Zebrafish Model Organism
Vertebrate endocrine system. Research using zebrafish as a vertebrate model
organism has been increasingly focused on questions relevant for human development
and diseases. The hypothalamo-pituitary axis, which links the central nervous system,
endocrine systems, and glands, has been shown to be highly conserved when comparing
to zebrafish to humans (Löhr & Hammerschmidt, 2011). Optogenetic research with
transgenic zebrafish has identified ER activity in response to both natural and synthetic
estrogens by observing fluorescence in estrogenic tissues such as the liver, ovary,
pituitary gland, and brain (Gorelick & Halpern, 2011).
Estrogen receptors. The zebrafish genome is known to code for three nuclear
estrogen receptors Esr1, Esr2a, and Esr2b, which mediate the genomic response to
estrogen signaling by acting as DNA-binding transcription factors. A fourth estrogen
targeted receptor is the membrane localized G protein-coupled estrogen receptor (Gper)
which induces activation of non-genomic responses. Importantly, the fetal expression of
estrogen receptors during development is induced at 24 hours post fertilization (hpf), the
most highly expressed of which appears to be Esr2a (Hao et al., 2013). Because estrogen
receptors first become active at 24 hpf, this period is critical in the context of examining
the effects of xenoestrogens on EA. BPA causes transactivation of all three nuclear
estrogen receptors, but showed the highest selective affinity towards zfERα (Esr1) with
an EC50 of 1µM and a relative estrogenic potency of 1.9 x 10-4 according to experiments
conducted in vitro cell lines (Le Fol et al., 2017).
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Biomarkers for estrogen activation (EA). Transcriptomic analysis of estrogen
target genes during zebrafish embryonic development identified several genes which
serve as biomarkers for EA. In particular, the brain-specific Cytochrome P450 aromatase
(Cyp19a1b) gene serves as a potent indicator of EA. Fluorescence can be detected as
early as 25-26hpf in Cyp19a1b:GFP transgenic fish treated with 10-8M of estradiol (E2;
Mouriec et al., 2009). The aromatase enzyme non-reversibly converts Testosterone into
Estrogen, so overexpression of Cyp19a1b can lead to a positive feedback loop where
more estrogen and subsequently more aromatase is created in the brain. Zebrafish plasma
E2 concentrations increase after BPA exposure (Zhao et al., 2017) which can be
attributed to increased aromatase expression. As the BPA dose increases, plasma
testosterone concentrations decrease dramatically, leading to an elevated E2/T ratio as the
pool of available testosterone is depleted (Zhao et al., 2017). Cyp19a1b mRNA
expression has been found to be highly upregulated by estrogen in the brain at 2-4 days
post fertilization (Hao et al., 2013). BPA exposure of 1μM in Cyp19a1b transgenic
zebrafish for 4 days (2hpf-4dpf) has been shown to induce a 16-fold fluorescence
intensity increase compared to DMSO control which has basal GFP fluorescence
equivalent to water-only treatment (Cano-Nicolau et al., 2016).
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Figure 3. Fluorescence image of 5dpf Cyp19a1b:GFP zebrafish exposed to BPA. The
left image shows a control fish which received no BPA treatment. The right image shows
a fish raised in BPA 2.5μM solution from 0-5dpf. Figure sourced from Brion et al.
(2012). Poa = preoptic area.
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The relative estrogenic potency of BPA (compared to endogenous E2) has been
reported to be 1.44 x 10-4 using the Cyp19a1b:GFP transgenic line, indicating a low
binding affinity (Brion et al., 2012). The LC50 (Lethal Concentration for 50% of exposed
animals) of BPA was measured in Cyp19a1b:GFP zebrafish and found to be 4.7e-5 mol/L
(47μM), and GFP expression decreased at the highest concentrations which is consistent
with the increase in mortality. Furthermore, the EC50 (Effective Concentration for 50%
of maximal response) of BPA for GFP induction in this line was found to be 7.4e-6 mol/L
(7.4μM; Petersen et al., 2013).

Radial Glial Cells
An interesting characteristic of Cyp19a1b is its exclusive expression in radial glial
cells (RGC) due to the mandatory cooperation between ERs and a “glial”-specific factor
(Gx) that binds upstream of the Cyp19a1b promotor (Le Page, Vosges, Servili, Brion, &
Kah, 2011). The development of a transgenic Cyp19a1b:GFP zebrafish line which
expresses green fluorescent protein in response to the brain aromatase Cyp19a1b
promotor has become a useful tool for direct evaluation of xenoestrogens’ EA and
characterization of radial glia in the developing brain (Tong et al., 2009). Effect-directed
analysis used in tandem with Cyp19a1b:GFP zebrafish embryos have recently shown
success in detecting the presence of estrogenic compounds in fluvial sediment samples
from the Czech river Bilina (Fetter et al., 2014).
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Figure 4. Mechanisms of Cyp19a1b upregulation by estrogens. Figure sourced from Le
Page et al. (2011). “Mechanisms of cyp19a1b upregulation by estrogens (E2),
xenoestrogens (xE2), or aromatizable androgens (testosterone, T) in the radial glial cells
in the brain of fish. A mandatory cooperation between estrogen receptors and a “glial”specific factor (Gx) that binds onto a GxRE sequence upstream from the ERE results in a
high sensitivity of the cyp19a1b gene to E2 or xE2. As radial glial cells have aromatase
activity, testosterone also upregulates aromatase B expression.”
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Fluorescence readings from a Cyp19a1b:EGFP (enhanced green fluorescent
protein) line have shown that E2-treated embryos produced EGFP localized in the
olfactory bulb, telencephalon, preoptic area, and mediobasal hypothalamus of the
forebrain, which was first detected 3d after treatment and increased until 5dpf (Kim et al.,
2009). Furthermore, whole-mount in situ hybridizations have shown that BPA (5μM)
induces AroB overexpression in similar patterns to estrogen in the developing zebrafish
brain and that the first 5dpf exposure window is the most sensitive, especially the 7296hpf period (Chung, Genco, Megrelis, & Ruderman, 2011). Fluorescence does not
appear to be induced in the hindbrain regions of zebrafish, which is consistent with a
study on aromatase expression in the Japanese eel (a basal teleost) that found no cyp19a1
mRNA within the cerebellum or medulla oblongata, but did find expression in the
telencephalon, preoptic area, and hypothalamus (Jeng et al., 2012). This indicates that
the hindbrain can be a reference region to compare against the forebrain to examine
localized effects of increased aromatase expression.
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Figure 5. Fluorescence image of 8dpf Cyp19a1b:GFP zebrafish exposed to Estradiol.
Larvae were raised in 10nM Estradiol solution from 0-5dpf. Figure sourced from Brion
et al. (2012). A & B: Ob = Olfactory bulb, tel = Telencephalon, poa = Preoptic Area,
nrp = Nucleus recessus posterioris of caudal hypothalamus, nrl = Nucleus recessus
lateralis of caudal hypothalamus. C: S = Soma, nb = newborn cells, rp = radial
processes, ef = end-feet.
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Figure 6. High-resolution fluorescence image of 6dpf Cyp19a1b:GFP zebrafish. Image
taken in the HSU Graduate Psychology Research Lab. Results confirm that aromatase
expression in radial glial cells follows the same patterns observed from Cyp19a1b:GFP
zebrafish in research labs referenced for this thesis.
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Progenitor cells. Zebrafish radial glial cells (RGC) act as progenitor cells which
guide early brain development and persist into adulthood, whereas mammalian radial glia
disappear shortly after birth (Schmidt, Strähle, & Scholpp, 2013). These progenitors are
asymmetrically dividing stem cells which reside in the embryonic ventricular zone and
generate neurons in addition to new radial glia. During development, they act as
scaffolds for new neurons which use their long processes to migrate out of the ventricular
zone (Schmidt et al., 2013).
Neurogenesis. Characterization of radial glia is of the utmost importance in the
context of zebrafish embryonic neurogenesis. Proliferating cells in the developing
hypothalamus express sex steroid receptors and undergo a period of neurogenesis from
16hpf-36hpf, representing a window of vulnerability to xenoestrogen exposure (Kinch,
Ibhazehiebo, Jeon, Habibi, & Kurrasch, 2015). Kinch and colleagues were able to
demonstrate through EdU pulse-labeling that very low dose exposure to BPA
(0.0068μM) from 0-5dpf increased the number of newly born neurons in the
hypothalamus by 180% at 24hpf. They also noted a 60% decrease in newly born neurons
by 36hpf, which indicates that the precocious neurogenesis at 24hpf had exhausted a
portion of the progenitor pool, and that the effects on neurogenesis were limited to the
hypothalamus. It is worth noting that a higher dose of 100μg/L (~0.44μM) of BPA has
been shown to increase hypothalamic gonadotropin-releasing hormone (GnRH3) neuron
numbers at 25hpf (Qiu et al., 2016). Experiments using mice show that E2 treatment in
the embryonic neocortex can rapidly promote neural proliferation (Martínez-Cerdeño,
Noctor, & Kriegstein, 2006).
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Recent research conducted by Pérez and colleagues demonstrated for the first
time that a close relationship exists between 5-HT neurons and radial glial cells in the
hypothalamus. Newborn cells generated by RGC in adult zebrafish can migrate
centripetally and differentiate into 5-HT neurons. 5-HT cell bodies become tightly
packed and localized close to the diencephalic ventricles or their recessi and contact
cerebral spinal fluid-(CSF) by extending a short process toward the lumen of the
ventricle. 5-HT cell bodies remain closely associated with RGC, where RGC form a
continuous barrier along the ventricles through cytoplasmic processes which interconnect
with one another, and the proximal 5-HT cells’ processes cross this barrier through small
pores into the ventricular lumen to contact CSF. Interestingly, addition of a selective
irreversible inhibitor of tryptophan hydroxylase (Fenclonine), used to cause a decrease in
5-HT content, was shown to decrease cell proliferation in the caudal hypothalamus of
adult zebrafish (Pérez et al., 2013). These discoveries bring into question how the
disruption of RGCs by xenoestrogens might affect the proliferation of 5-HT neurons in
the hypothalamus during early development.
A review paper on BPA’s interaction with brain development and function notes
that there are still very few results in the literature about its effects on pluripotent cells.
They state that BPA has been demonstrated to disrupt neurogenesis by influencing neural
stem cell proliferation and viability, modifying stem cell fate, and by promoting neural
progenitor differentiation into neurons. It is suggested that since correct neuronal
positioning relates to normal brain circuitry, BPA exposure’s modifications of these
processes may lead to abnormal brain connectivity in some areas (Negri-Cesi, 2015).
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Adult proliferation and neurogenesis recapitulate some of the molecular and
cellular mechanisms used during embryonic development of the CNS (Kaslin, Ganz, &
Brand, 2008). Therefore, discoveries from studies on adult neurogenesis may still have
important applications in the context of embryonic neurogenesis.

Estrogenic Effects on Neurons
Calcium activity. Rat studies demonstrate that estradiol (E2) enhances the
depolarizing action of GABA in developing hypothalamic neurons by increasing the
magnitude of the calcium transient with each depolarization, increasing the number of
neurons that respond to GABAA receptor activation with a calcium transient, and
extending the developmental duration of depolarizing GABA action (McCarthy, 2008).
Currently there is difficulty establishing the functional significance of this effect because
the only known way of enhancing GABA’s depolarizing action is by E2 administration.
Gene expression and development. Embryonic zebrafish (3dpf) show highly
comparable expression of genes and GABA cell patterns to mice at the neurogenic time
window. At 3dpf zebrafish produce GABA in the subpallium, preoptic region, ventral
and dorsal thalamus, and the hypothalamus (Mueller, Vernier, & Wullimann, 2005).
Interestingly, most dopaminergic neurons also express GABAergic markers, and all
catecholaminergic groups in zebrafish exhibit a dual transmitter phenotype of either a
GABAergic or glutamatergic nature (Filippi, Mueller, & Driever, 2014). There is
evidence that dopamine may upregulate Cyp19a1b mRNAs through D1 receptors, and
stimulates RGC function through neuronal-glial interactions in teleost fish via the
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D1R/cAMP/PKA/p-CREB pathway (Xing, McDonald, Da Fonte, Guiterrez-Villagomez,
& Trudeau, 2015).
In early zebrafish development GABA acts as an excitatory neurotransmitter due
to immature neurons initially expressing the NKCC1 transporter responsible for chloride
uptake, but not the neuron-specific extrusive KCC2 transporter (expression first detected
at approximately the time of hatching – 2dpf). Experiments where KCC2 was
overexpressed before the onset of endogenous expression led to an early reversal of the
chloride gradient, the proportion of spontaneously active neurons decreased and the
number of silent neurons increased. KCC2 overexpression also led to perturbed
development with multiple abnormal morphological features (overall smaller embryos,
reduced head & eye size, pigmentless, increased tail curvature) and slow coils in response
to touch. Reduced neurogenesis and diminished axon maturation were observed in both
the brain and hindbrain, where significantly less newly differentiated neurons were found
due to impaired birth of neurons (notably interneurons and motor neurons) without
affecting the proliferation or death of progenitors (Reynolds et al., 2008). The results of
this study display the importance of GABA’s excitatory role during early neurogenesis
and its guidance on morphological development of both the brain and body.
Zebrafish embryos exposed to BPA (50μM) at the prim-5 stage (24hpf) alters
brain development by disturbing the process of brain regionalization, resulting in the
development of abnormal rhombomeres, a restricted Mhb (Midbrain-hindbrain
boundary), and a smaller midbrain structure (Tse, Yeung, Wan, & Wong, 2013). EE2
exposure disrupts ontogeny of GnRH system by inducing an increased number of GnRH-
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ir neurons and fibers, decrease the size of soma, and modify migration profile in a dosedependent manner (Vosges et al., 2010).
BPA treatment (5mg/kg IP) on pregnant mice increased in utero Hoxa10
(homeobox gene that controls developmental organogenesis) expression and decreased
cytosine-guanine methylation in the promotor and intron sequences of Hoxa10; this led to
increased binding of ER-α to the Hoxa10 ERE both in vitro and in vivo, which in turn led
to increased ERE-driven gene expression (Bromer, Zhou, M. Taylor, Doherty, & H.
Taylor, 2010). This indicates that there is an additional epigenetic mechanism by which
BPA can alter expression of estrogen-responsive genes and disrupt developmental
programming.
Locomotor activity. There appears to be a dose-response relationship between
BPA and swim activity. Swim hyperactivity has been defined as an abnormally fast
swimming over an extended period, typically related to psychostimulant/convulsant
action or anxiety-like behavior (Kalueff et al., 2013). BPA exposure of 0.1μM to larval
zebrafish during the window of hypothalamic neurogenesis (16-36hpf) induces
hyperactive behaviors (~300% increase in locomotor activity) at 5dpf (Kinch et al.,
2015). A similar study had a 48-hour BPA exposure period begin at 8-10hpf and
measured swim behavior at 5dpf; 0.01μM and 0.1μM doses resulted in larval
hyperactivity whereas the higher 1μM and 10μM concentrations did not affect activity
(Saili et al., 2012). However, an even higher dose of 15μM BPA from 6hpf-4dpf results
in significantly decreased swimming behaviors measured at 5dpf (Wang et al., 2013).
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Together, these results may indicate an inverse-U dose-response curve for BPA
concentration and zebrafish swimming activity.
Brustein and colleagues demonstrated a relationship between 5-HT and locomotor
activity. They note that locally restricted populations of serotonergic neurons and their
projections appear in the hindbrain and spinal cord by 2dpf, and that 5-HT acts as a
neuromodulator integrated into the locomotor network to affect swimming activity from
4dpf onwards. 5-HT was found to reduce intervals of inactivity (quiescence) but had
little effect on the properties of activity periods (Brustein, Ghong, Holmqyist, & Drapeau,
2003). Further research clarifies that 5-HT modulates the quiescence period by
increasing the amplitude of the chloride response by 40% when glycine is applied, this
causes an increase in depolarization which is reflected behaviorally through doubling the
number of swim episodes (Brustein & Drapeau, 2005).
Dopaminergic neurons within the zebrafish hypothalamus have recently been
shown to mediate locomotor activity. Activation of Tyrosine Hydroxylase (TH)-positive
neurons in the posterior recess through optogenetic transgene mechanisms resulted in an
increased frequency of swimming and displacement compared to controls, suggesting
either a role in direct activation or modulation of the threshold of motor response to
sensory-evoked stimuli. Furthermore, ablation of these neurons reduced both the number
of spontaneous swimming episodes and the time spent swimming, and restoration of TH
neurons correlated with recovery of swimming deficits (McPherson et al., 2016).
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Zebrafish Elavl3 (HuC Homologue)
Zebrafish Elavl3 is a HuC homologue which has been demonstrated to be one of
the earliest markers for the identification of neuronal fate (Kim et al., 1996). Its
expression is initiated in embryonic cells that are committed to developing into neurons,
and it continues expression during all stages of neuronal development. Mutations can
lead to a lethal phenotype during embryogenesis due to the degeneration of the CNS,
indicating Elavl3 may be important for the development and maintenance of the nervous
system (Park et al., 2000a).
A study looking to detail neurogenesis in the adult zebrafish brain used BrdU
pulse-labeling experiments to detect proliferating cells in combination with HuC,
Tyrosine hydroxylase (TH), and 5-HT immunostaining to detect newborn cells
expressing distinct neuronal phenotypes. They found that proliferation zones existed
throughout the entire anterior-posterior axis of the brain and that newborn cells move
centrifugally into the surrounding mantle after differentiating into neurons. Importantly,
they were able to identify TH-positive newborn neurons in multiple regions (mostly the
preoptic area) as well as 5-HT-positive newborn neurons in the ventral periventricular
hypothalamus (Grandel, Kaslin, Ganz, Wenzel, & Brand, 2006).
Development of the first stable line of HuC-GFP transgenic zebrafish which
exhibit fluorescence in newly born neurons was done by Hae-Chul Park and colleagues
(2000b). GFP fluorescence was found as early as 12hpf, and by 24hpf all early brain
tracts and nuclei were recognized by anti-GFP labeling. They further demonstrated the
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usefulness of the line as a tool for characterizing neurogenesis mutants by crossing HuCGFP fish with the mib mutant zebrafish, which exhibits excessive early differentiating
neurons, and found that neuronal hyperplasia was present due to there being much more
intense GFP fluorescence in the double mutants compared to the HuC-GFP embryos.
Elavl3:GCaMP transgenic zebrafish line. Elavl3:GCaMP is another transgenic
line utilizing the Elavl3 promotor which has a genetically encoded calcium indicator that
fluoresces in the presence of calcium. The GFP in GCaMP is fused to Calmodulin, a
protein which binds up to four Ca2+ ions, and undergoes a conformation change upon
Ca2+ binding which results in bright fluorescence compared to the unbound state. This
GCaMP line can be used to measure changes in spontaneous calcium dynamics within
the brain caused by electrical activity.
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Figure 7. Fluorescence image stack of 6dpf Elavl3:GCaMP zebrafish hypothalamus.
Region A = “DC7” dopaminergic cluster. Image taken in the HSU Graduate Psychology
Research Lab. Results are consistent with Elavl3:GCaMP images provided by the Z
Brain Atlas created by the Engert Lab at Harvard University.
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Statement of the Problem

Until manufacturing processes adapt to use non-EDC components in plastic
production, the problem of EDCs affecting organisms will persist. Substitute chemicals
for plastic production which do not have EA properties have indeed been discovered, but
lack of regulation and recycling of products containing EDCs means that they will an
ever-present issue. Further research clarifying the effects of xenoestrogen exposure on
early development is important because exposure is widespread and may have lasting
consequences. BPA has been a focal point in the research of EDCs due to its EA ability
at low doses, but only in the past decade has its effects on the brain begun to be
investigated. Changes in brain development and behavior have been noted in zebrafish,
but there remains the question of how calcium activity may be related to these changes.
The current study seeks to replicate recent findings while exploring potential mechanisms
by which the changes in neural activity might be responsible for later behavioral changes.

Research Hypotheses and Rationale
Hypothesis 1a. Cyp19a1b:GFP zebrafish larvae treated with 0.1μM BPA from
1dpf-5dpf will see a small increase in GFP expression when measured at 6dpf compared
to the control group that does not receive treatment.
Hypothesis 1b. Cyp19a1b:GFP zebrafish larvae treated with 2.5μM BPA from
1dpf-5dpf will see a large increase in GFP expression compared to the control group that
does not receive treatment.
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Rationale. Replication is necessary to confirm BPA exposure causes Estrogen
Activation (EA) which increases expression of Cyp19a1b within radial glial cells.
Hypothesis 2. Elavl3:GCaMP zebrafish larvae treated with 0.1μM BPA from
1dpf-5dpf will see an increase in spontaneous Ca2+ oscillations within the hypothalamus
and medulla at 6dpf compared to the control group that does not receive treatment.
Rationale. EA enhances GABA’s depolarizing action on hypothalamic neurons
during early development by increasing calcium transit with each depolarization and
decreasing threshold for depolarization. If these neurons also regulate motor behavior
through a projection to the medulla then it may lead to more Ca2+ activity there as well.
Hypothesis 3. Elavl3:GCaMP zebrafish larvae treated with 0.1μM BPA from
1dpf-5dpf will see an increase in swimming activity due to decreased quiescence periods
at 6dpf compared to the control group that does not receive treatment.
Rationale. EA leads to an overactive hypothalamus, a locomotion modulator,
which translates into decreased periods of quiescence and therefore more swim episodes.
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Method

Instruments
Microscope: Olympus Fluoview FV1000 with 20x .95NA water immersion lens.
Camera: Pixelink PLB-741 with IR illumination and visible light blocking filter.
Software programs: ImageJ for image analysis, R for statistical tests.
ImageJ plugins: Image Stabilizer (Li & Kang, 2008).

Subjects
Initial power analyses indicated that a total of 504 zebrafish larvae would be
needed for all experimental comparisons and up to 30 adults will be used to generate
these larvae. The Humboldt State University IACUC approved the use of animals for
this research (protocol no. 17/18.P.34-A). It is worth noting that this study used
significantly less specimens than indicated by a prior power analysis. Studies in this field
conducted by leading research labs tend to use much smaller sample sizes in the range of
as few as 6 subjects to as many as 20 subjects for any given measurement.
A total of N = 245 fish were examined across all experiments. For the
Cyp19a1b:GFP experiment, 42 subjects were examined: 0.1μM vs control groups n = 15
each, 2.5μM vs control groups n = 6 each. For the Elavl3:GCaMP experiment, 57
subjects were examined: 0.1μM group n = 28, control group n = 29. For the Behavior
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experiment, 146 subjects were examined: 0.1μM group n = 73, control group n = 73. All
subjects were confirmed to be sufficiently healthy as indicated by inflated swim bladders.

Experimental Design
Experiment 1. Cyp19a1b:GFP zebrafish larvae (n = 42) were divided into two
separate exposure protocols for fluorescence imaging to detect AroB expression in radial
glia. The first protocol tested a dose of 0.1μM BPA (n = 15) against a control group (n =
15). The second protocol tested a dose of 2.5μM BPA (n = 6) against a control group (n
= 6). The second protocol was added through an IACUC amendment as a validity check
to test whether the chemical delivery method was effective. A small effect size was
expected for the 0.1μM BPA group, where exposure results in a small but detectable
increase in fluorescence due to increased AroB expression. A large effect size was
expected for the 2.5μM BPA group, where exposure results in a large and easily
detectable increase in fluorescence due to increased AroB expression.
Experiment 2. Elavl3:GCaMP zebrafish larvae (n = 57) were divided into two
groups for Ca2+ activity recordings. A dose of 0.1μM BPA (n = 28) was compared
against a control group (n = 29). Recordings of both the hypothalamus and medulla were
taken within each fish at separate intervals. A medium effect size was expected where
BPA exposure results in approximately two-fold the amount of dynamic Ca2+ oscillations
within the hypothalamus and medulla.
Experiment 3. Zebrafish larvae (n = 146) were divided evenly into groups for
spontaneous swim activity recordings. A dose of 0.1μM BPA (n = 73) was compared
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against a control group (n = 73). A medium effect size was expected where BPA
exposure results in approximately two-fold the amount of time spent swimming.

Procedure
Drug exposure. 10,000x stock solutions of 1mM and 25mM BPA [239658,
Sigma-Aldrich] dissolved in DMSO (Dimethyl sulfoxide) were prepared and stored
frozen. Exposure groups were raised in 60mm glass petri dishes (up to 30 larvae each)
containing either 0.1μM BPA or 2.5μM BPA in embryo water (0.01% DMSO) for 5 days
(1dpf-5dpf) before imaging on day 6. Control groups were raised in 60mm glass petri
dishes containing an equal volume of DMSO solvent in embryo water with no BPA. The
volume of embryo water solution in each dish was 20mL and half of this volume was
replaced daily for both experimental and control groups. Dead or sick larvae were
removed from petri dishes upon discovery when changing water. On day 6 the larvae
were removed and transferred to clean embryo water for imaging and behavioral testing.
Embedding. Larvae were anesthetized for about 2 minutes using MS-222 to
allow agar embedding, which lets experimenters position the larvae as needed on the
microscope slide. 0.01% (w/v) MS-222 solution was be made fresh for each experiment
by dissolving MS-222 and an equal weight of sodium bicarbonate (to maintain neutral
pH) in embryo water. Larval fish were first transferred individually by plastic suction
pipette from their home dishes to the MS-222 solution dish and watched closely for the
onset of paralysis (usually within 30 seconds), and then pipetted onto a microscope slide
for embedding.
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To begin agar embedding, a drop of low melting temperature agar (1.3% w/v
dissolved in embryo water at neutral pH) was placed to harden on a microscope cover
glass, then a straight channel was cut into it with a razor blade. An anesthetized larva
was pipetted into the agar channel with the dorsal side of the head touching the glass
cover slip. A moistened Kimwipe was used to move the larvae into the correct position
while absorbing excess water. Then, a drop of melted agar (< 32°C) was gently pipetted
onto the positioned larva and allowed to harden, finishing the embedding process.
Larvae were left embedded for at least 20 minutes on a slide warmer before imaging to
acclimate them to the agar medium and allow the effect of MS-222 to wear off. After
imaging was completed, larvae were de-embedded by gently dissecting agar away with a
blunt tool underneath a dissecting microscope, then the freed larva is introduced to a
clean petri dish containing fresh fish water and returned to the incubator.

TEST OF BPA’S ESTROGENIC EFFECTS IN ZEBRAFISH

31

Figure 8. Zebrafish larva embedded in agar. Image taken in the HSU Graduate
Psychology Research Lab. Larva is embedded in 1.3% agar solution with the dorsal side
of the fish’s head positioned against the glass slide.
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Microscope imaging. An Olympus Fluoview FV1000 confocal laser scanning
microscope was used to image both the Cyp19a1b:GFP and Elavl3:GCaMP larvae. The
fluorescent confocal microscope illuminates cells with a narrow 488nm laser beam that
scans across the imaging field. To avoid damaging any cells, exposure to the laser was
limited to 30 minutes of intermittent scanning per larva with the minimum amount of
laser power required to take adequate images. The standardized settings used to image
each larva were as follows: 30% laser strength, HV = 536, Gain & Offset = 6, Zoom =
1.2x, 800x800 pixel image size, Capture rate = 2.0μs/pixel.
Cyp19a1b:GFP larvae were examined under the confocal microscope for the
presence of GFP and adequate dorsal alignment before taking z-stack images. Z-stacks
were standardized at 251 slices with a step size of 2.0μm, covering a 500μm depth from
the top to bottom of the head in 10 minutes of scanning. The head was centered in the
viewing frame so that the whole telencephalon and diencephalon was visible throughout
the imaging process.
Elavl3:GCaMP larvae were examined under the confocal microscope for the
presence of GCaMP and adequate dorsal alignment before taking time-lapse images.
Time-lapses were capped at 3,000 images taken over a 10-minute period with an image
capture interval set at 0.2s. The scanning area was cropped around the region of interest
(ROI) to permit a scanning rate of 0.145s +/- 0.002s. This was done both to ensure that
the areas being measured were the same size between subjects and that the capture rate
was fast enough to detect activity changes. Recordings of the hypothalamus and medulla
were taken in separate instances and were done on the same side of the brain.
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Swim activity test. BPA- and control-treated larvae were transferred via plastic
pipette individually into microplate wells containing 0.3mL of fish water. Fish were
arranged into alternating BPA and control columns for easy labeling. A digital camera
(Pixelink PLB-741) with a visible light-blocking, infrared-passing filter was placed above
the wells to record the swimming activity for 10 minutes by taking still images at a rate
of 5Hz. The inside of the recording chamber had an ambient temperature of 25-26°C.
The first 5 minutes of recording was taken with the lights on inside the recording
chamber to acclimate the fish to the environment. At the 5-minute mark, lights were
switched off and a small visual indicator was automatically turned on to indicate the
change. After recording, the larvae were removed by pipette and transferred into 60mm
petri dishes with fresh fish water.
Data analysis procedures. Cyp19a1b:GFP expression analysis was performed in
ImageJ using the depth-projection image stacks obtained from confocal imaging. For
each subject a 16-bit “Z-project: Max” images was created out of a 50-image stack that
ended at the bottom of the hypothalamus, then a Gaussian Blur filter with sigma value 1.0
was applied to decrease background noise. A standardized “Cyp19a1b ROI” was applied
to the z-projection which measured the mean pixel intensity of the whole ventral
hypothalamus and the midline of the preoptic area. A standardized “Reference ROI” was
also applied inside one of the eyes to measure the baseline pixel intensity. Measurements
were taken 5 times per subject to find the best fit, the highest “Cyp19a1b ROI” mean was
kept and the lowest “Reference ROI” mean was kept for each subject. The true pixel
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value caused by Cyp19a1b:GFP expression was calculated by subtracting the “Reference
ROI” mean from the “Cyp19a1b ROI” mean within each subject.
Elavl3:GCaMP activity analysis was performed in ImageJ using the time-lapse
image stacks obtained from confocal imaging. First, the hypothalamus and medulla timelapse stacks needed to be stabilized due to the presence of movement artifacts. The
Image Stabilizer plugin (Li & Kang, 2008) was used with the following settings:
Translation, Max pyramids 1, Coefficient 1, Maximum iterations 200, Error Tolerance
0.0000001. Then, for each subject 32-bit “Z-project: Standard Deviation” images were
created from both the hypothalamus and medulla stacks (3,000 images each). This
method measures the standard deviation from the mean across the stack, assigning higher
pixel values to pixels which have a high degree of change. This gives a measure of total
calcium activity over time in a given area but does not capture any information about
action potential frequency or neural circuitry. A standardized “GCaMP ROI” was drawn
around the viewing area captured during the imaging process and the mean pixel value
was calculated. A “Reference ROI” value was also taken outside the viewing area to act
as a baseline in a similar way to the Cyp19a1b analysis. The true pixel value caused by
calcium activity was taken by subtracting the “Reference ROI” mean from the “GCaMP
ROI” mean.
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Figure 9. Example of Cyp19a1b:GFP ROI procedures in ImageJ. Region A =
“Cyp19a1b ROI” measures pixel intensity due to GFP driven by Cyp19a1b expression.
Region B = “Reference ROI” measures background value to infer baseline.
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Figure 10. Example of Elavl3:GCaMP Hypothalamus ROI procedures in ImageJ.
Region A = “GCaMP ROI” measures standard deviation pixel values caused by Ca2+
fluctuations. Region B = “Reference ROI” measures background value to infer baseline.
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Figure 11. Example of Elavl3:GCaMP Medulla ROI procedures in ImageJ. Region A =
“GCaMP ROI” measures standard deviation pixel values caused by Ca2+ fluctuations.
Region B = “Reference ROI” measures background value to infer baseline.
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Figure 12. Example of “Image Stabilizer” procedure in ImageJ. A = Pre-stabilized
image, which has visible blurring of cells due to movement. B = Post-stabilized image,
which attempts to correct for movement artifacts and produces clearer cell boundaries.
The “Image Stabilizer” procedure results in lower mean standard deviation pixel values,
which would have otherwise been artificially inflated by movement artifacts.
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Behavior video was analyzed in ImageJ to measure swimming activity. First,
each frame of the video was subtracted from the previous frame, which resulted in a new
video showing only the pixels whose brightness changed from frame to frame (every
200ms). The video was then thresholded (pixel value = 7) so bright pixels corresponding
to the fish’s location could be detected automatically by the Particle Analysis function of
ImageJ. A ROI was then drawn around each well to assess whether the larvae had
changed position from one frame to the next (minimum 4x4 pixel area), allowing
calculation of percentage of time in motion. Percentage of time in motion was calculated
for both the “Light On” and “Light Off” periods, then the values were converted into
seconds of activity per minute of recording. In cases where movement could either not
be detected throughout the entire period or camera errors occurred, an “NA” value was
assigned so that the data was excluded from analysis.
Blinding procedures. Measures were taken to avoid potential experimenter bias
before data analysis was performed in ImageJ. An independent party gave nondescriptive names to data files and created a key showing which files belonged to which
group. The key was sealed until data analysis and statistics were completed by the
blinded investigators. Upon completion the key was opened to reveal the identity of the
BPA and Control groups.
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Figure 13. Example of behavioral analysis in ImageJ. Image A = Single unprocessed
image. Image B = Standard deviation projection image of swimming activity over time.
The overhead camera is easily able to track the movement of multiple fish in high detail.
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Results

Statistical Assumptions
The primary assumptions for the statistical tests performed in this study were
homogeneity of variance and normality of data. The criteria for homogeneity of variance
was set as being less than a 4:1 ratio between groups. Normality of data was checked in
R by calculating skew, kurtosis, and examining histogram charts. All datasets appeared
to have a relatively normal distribution which did not require transformation. t-tests were
performed using two-tails so that the significance threshold was more conservative.

Cyp19a1b:GFP Expression Analysis
0.1μM BPA vs control. Results did not find a significant difference in
fluorescence between the 0.1μM BPA group (M = 61.473, SD = 21.829) and the
corresponding control group (M = 60.266, SD = 15.064), t(28) = 0.176 , p = .861, d =
0.064. The 95% CI around the difference between the means was [-12.820, 15.235]. The
independent two sample t-test was calculated with the homogeneity of variance
assumption being met (2.1:1).
2.5μM BPA vs control. Results showed a significant difference in fluorescence
between the 2.5μM BPA group (M = 147.982, SD = 32.795) and the corresponding
control group (M = 43.645, SD = 9.949), t(5.9) = 7.457, p < .001, d = 4.306. The 95% CI
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around the difference between the means was [69.979, 138.695]. Welch’s two sample ttest was used because the homogeneity of variance assumption was not met (10.9:1).
Post hoc analysis. An ANOVA performed on all groups found that the dose
condition did have an overall significant influence on the amount of fluorescence
detected, F(3,38) = 34.76, p < 0.001, partial η2 = 0.733 . Post hoc comparisons using the
Tukey test indicated that the 2.5μM BPA group had a significantly higher mean than all
other groups, but no other comparisons were found to be significant.
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Table 1
Cyp19a1b:GFP Experiment Descriptive Statistics
Group

n

BPA conc.

M

SD

s2

BPA 0.1μM

15

0.1μM

61.473

21.829

476.485

CTRL 0.1μM

15

0μM

60.266

15.064

226.931

BPA 2.5μM

6

2.5μM

147.982

32.795

1075.537

CTRL 2.5μM

6

0μM

43.645

9.949

98.976

Note. M units: Mean of pixel gray-values within ROI after removing background value.
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Table 2
Cyp19a1b:GFP Multiple Comparisons of Means: Tukey Contrasts
Linear Hypotheses

t

p

d

BPA 2.5μM – CTRL 2.5μM

8.885

< 0.001*

4.306

BPA 2.5μM – CTRL 0.1μM

8.928

< 0.001*

3.437

BPA 2.5μM – BPA 0.1μM

8.805

< 0.001*

3.105

BPA 0.1μM – CTRL 2.5μM

1.815

0.277

1.051

CTRL 0.1μM – CTRL 2.5μM

1.692

0.337

1.302

BPA 0.1μM – CTRL 0.1μM

0.163

0.998

0.064

Note. *p < .05 for pairwise comparison.
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Elavl3:GCaMP Activity Analysis
Hypothalamus activity. Results did not find a significant difference between the
0.1μM BPA group (M = 48.245, SD = 18.058) and the control group (M = 41.616, SD =
22.885), t(55) = 1.213, p = .230, d = 0.321. The 95% CI around the difference between
the means was [-4.330, 17.607]. The independent two sample t-test was calculated with
the homogeneity of variance assumption being met (1.6:1).
Medulla activity. Results did not find a significant difference between the
0.1μM BPA group (M = 179.290, SD = 58.562) and the control group (M = 165.409, SD
= 81.705), t(55)= 0.735, p = .466, d = 0.195. The 95% CI around the difference between
the means was [-23.971, 51.732]. The independent two sample t-test was calculated with
the homogeneity of variance assumption being met (1.95:1).
Within-subject hypothalamus/medulla activity ratio. Results did not find a
significant difference between the 0.1μM BPA group (M = 0.283, SD = 0.104) and the
control group (M = 0.271, SD = 0.130), t(55) = 0.403, p = .689, d = 0.107. The 95% CI
around the difference between the means was [-0.050, 0.075]. The independent two
sample t-test was calculated with the homogeneity of variance assumption being met
(1.55:1).
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Table 3
Elavl3:GCaMP Experiment Descriptive Statistics
Measurement

Group

n

M

SD

s2

BPA

28

48.254

18.058

326.105

CTRL

29

41.616

22.885

523.728

BPA

28

179.290

58.562

3429.526

CTRL

29

165.409

81.705

6675.669

BPA

28

0.283

0.104

0.011

CTRL

29

0.271

0.130

0.017

Hypothalamus

Medulla

Hyp/Med Ratio

Note. M units: Mean of pixel gray-values within ROI after removing background value.
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Spontaneous Swim Activity Analysis
Light-on swim activity. Results did not find a significant difference between the
0.1μM BPA group (M = 12.68, SD = 12.36) and the control group (M = 12.93, SD =
12.38), t(118) = -0.11, p = .912, d = 0.02. The 95% CI around the difference between the
means was [-4.724, 4.225]. The independent two sample t-test was calculated with the
homogeneity of variance assumption being met (0.99:1).
Light-off swim activity. Results did not find a significant difference between the
0.1μM BPA group (M = 29.66, SD = 9.16) and the control group (M = 29.61, SD = 7.51),
t(144) = 0.037, p = .970, d = 0.006. The 95% CI around the difference between the
means was [-2.689, 2.792]. The independent two sample t-test was calculated with the
homogeneity of variance assumption being met (1.48:1).
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Table 4
Spontaneous Swim Activity Descriptive Statistics
Light Period

Group

n

M

SD

s2

On

BPA

62 (11 NA)

12.681

12.360

152.773

CTRL

58 (15 NA)

12.930

12.378

153.205

BPA

73

29.658

9.159

83.900

CTRL

73

29.606

7.510

56.406

Off

Note. M units: Seconds of movement per minute of recording. NA: Subject data
excluded from analyses due to there being no detectable movement throughout the
measurement period or due to the incidence of camera errors.
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Discussion

Review of the Findings and Literature
The main goal of this study was to identify a potential mechanism by which a
relatively low level of exposure (0.1μM) to BPA during development causes
hyperlocomotion in larval zebrafish. Although previous studies documented
relationships between BPA and swim behavior, the question remained what observable
changes in brain activity resulted in swim activity differences. Some evidence suggested
that the hypothalamus may modulate certain aspects of swim behavior in zebrafish
(McPherson et al., 2016), and since the hypothalamus is a region rich in Cyp19a1b
expression during larval neurogenesis (Kinch et al., 2015), I hypothesized that BPA may
be causing neural hyperactivity within the hypothalamus due to estrogen stimulation and
the neural hyperactivity producing a calcium transit (McCarthy, 2008). Two brain
regions, the “DC7” region of the ventral hypothalamus and the anterior medulla, were
selected to test this hypothesis in the Elavl3:GCaMP line. The study was unable to find
any difference in calcium activity between 0.1μM BPA-treated and control-treated fish in
these regions at 6dpf. To validate the findings of the main hypothesis, two other
hypotheses were tested concurrently to replicate previous findings.
In the first replication, 6dpf Cyp19a1b:GFP larvae were used to test whether
0.1μM BPA caused a significant increase in Cyp19a1b expression as indicated by GFP
fluorescence. Despite a reasonable sample size of 12 fish per group (10-15 per condition
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in Brion et al., 2012), there were no detectable differences in fluorescence between BPA
and control-treated fish at this dose. I was unable to find literature that confirmed an
increase of fluorescence at doses below 1.0μM, the dose response curve generated by
Brion et al. (2012) Fig. 3b did not indicate any increase at a 100nM (0.1μM) dose.
Another study using real time RT-qPCR did find a 9-fold induction of Cyp19a1b
transcripts at 0.1μM (Cano-Nicolau et al., 2016), which justifies the attempt to test for
fluorescence change in the Cyp19a1b:GFP line at this dose. This leaves questions about
differences between the sensitivity of in vivo and in vitro methods for testing gene
expression of Cyp19a1b, which have been generally thought to be highly correlated. As
a validity check, I also tested a higher dose of 2.5μM BPA which produced a 3.4-fold
increase in fluorescence compared to the control group. Although significant, these
results indicate a weaker effect compared to one study finding 16-fold GFP induction at
1.0μM (Cano-Nicolau et al., 2016) and another finding an EC50 of 3.3μM with a max fold
induction of 11.5 (Brion et al., 2012). The method of in vivo fluorescence quantification
used in this study was remarkably similar to those used in Cano-Nicolau et al. (2016) and
Brion et al. (2012), using ImageJ software to measure the sum of gray-values of pixels
within the region of interest while compensating for the background gray-value. One
notable difference is that these studies used a 10x objective lens with a 134ms exposure
time and maximal intensity, while the current study used a 20x .95NA water immersion
lens that scanned the entire head at a lower intensity over a 10-minute period. Another
potential difference is that the image analysis used in this study had an ROI surrounding
the hypothalamus and midline of the telencephalon on a select subset of image slices,
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which is likely different than what similar studies used. The inability of this study to find
a difference in Cyp19a1b expression using confocal fluorescence microscopy at a 0.1μM
BPA concentration may indicate that it is not an ideal method for quantification of
estrogenic activity at doses below 1.0μM BPA, or simply that the methods need more
refinement to detect differences at this lower dose. It also does not exclude the
possibility that there was in fact an estrogenic effect at that dose that could have been
detected by a more sensitive method such as qPCR. However, the absence of behavioral
effects at that concentration builds confidence in the conclusion that there was no
estrogenic effect at 0.1µM.
In the second replication, 6dpf zebrafish larvae from either transgenic line were
used to test whether 0.1μM BPA increased spontaneous swim activity in both light and
dark periods. Surprisingly, this study found no overall differences in swim activity
despite a large sample size of 73 fish per group being used. I attempted to replicate
methods used by two previous studies, Saili et al. (2012) and Kinch et al. (2015), which
both found larval hyperactivity after 0.1μM BPA exposure, the latter of which had
successfully replicated the results of the first. Both studies tested at 5dpf, housed larvae
in a 96-well plate, and acclimated the fish to light for 20 minutes before recording
locomotor activities during 5 minutes of darkness. They tracked locomotor activities at
30 frames per second with a 5-or-more pixel difference between frames being set as the
threshold, and the duration of hyperactivity bursts being measured in seconds per minute
for each larva. Each of these methodological aspects were very similar to how the
methods of the current study was carried out. This study measured at 6dpf, housed larvae
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in a 96-well plate, acclimated fish to light for 5-6 minutes before recording for 5 minutes
of darkness, and used a 7-or-more pixel difference between frames as the threshold. To
remain consistent with previous studies which calculated the duration of hyperactive
bursts in seconds per minute, this study simply calculated the overall percentage of
frames spent moving and then converted them into seconds of activity per minute. Small
differences between previous studies and the current study were also noted. Previous
studies used sample sizes of 5-10 per group (Kinch et al., 2015) and 42-47 per group
(Saili et al., 2012), which are less than the sample size of 73 per group used in the current
study. Also noteworthy is that the 30 frames per second framerate described in Saili et al.
(2012) is faster than the 5 frames per second used in the current study. Another
potentially significant difference is that Saili et al. (2012) maintained an ambient
temperature of 28°C in their testing chamber, while the current study had a temperature
in the range of 25-26°C. Despite these differences, they do not seem substantial enough
to explain the failure to replicate the larval swim hyperlocomotion hypothesis. Kinch et
al. (2015) found a 2.8-2.9-fold increase in swim activity in 0.1μM BPA exposed fish
compared to controls, while Saili et al. (2012) found that 0.1μM BPA exposed fish had a
movement duration of 24 seconds per minute compared to 16 seconds per minute in
control fish (Fig. 3b). The current study’s findings that the 0.1μM BPA and control
groups both spent approximately 30 seconds per minute moving during the dark period is
unexpected and raises questions about what may have caused this result. One notable
difference between our results and those of Saili et al. (2012) is that our larvae were more
active overall, particularly the untreated control larvae. Kinch et al. (2015) did not report
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swimming activity in absolute units, only group differences, and it remains unknown how
differences in baseline activity may affect the BPA response.

Limitations
One limitation of the current study relates to how neural activity was quantified.
The calcium activity measurement of this study is unable to draw any information about
action potential frequencies or the pattern of activity across different neurons. Taking the
standard deviation projection over time gives a brightness value for each pixel, with
brighter values being assigned to pixels that exhibited larger degrees of change over time.
This is a logical way to measure total Ca2+ fluctuation over time, however, it is a novel
method that has not yet been independently validated. One method to validate this
method would be to compare GCaMP dynamics between control larvae and those treated
with the anesthetic, MS-222, which blocks voltage gated sodium channels on neurons and
is known to greatly inhibit GCaMP dynamics (Fosque et al., 2015).
Another consideration is the brain areas I selected to measure BPA-induced
activation. In this study only two small subsections of the hypothalamus and medulla
were selected to measure Ca2+ activity, however, other regions may have also been
affected by the drug. The DC7 dopaminergic cluster of the ventral hypothalamus was
selected because of dopamine’s well-known involvement in locomotive behavior; while
the anterior medulla was selected due to the prominence of descending motor neurons
that exhibit calcium responses which initiate movement (Gahtan, Sankrithi, Campos, &
O’Malley, 2002). Whether these two regions have an integrated neural circuit has not
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been established, so the hypothesis that the DC7 cluster modulates anterior medulla
activity may not have been well-founded. A subsequent review of the literature revealed
research that shows dopaminergic clusters DC2, DC4, DC5, and DC6 within the
hypothalamus have confirmed axonal projections into the hindbrain (Leng Tay,
Ronneberger, Ryu, Nitschke, & Driever, 2011). DC7 was not amongst the clusters listed
that project the hindbrain, and instead only had local projections to the surrounding
hypothalamus and posterior recess. Furthermore, what I believed to be the DC7 cluster in
the Elavl3:GCaMP line was not confirmed by anti-TH staining or by cross-comparison to
our own DAT:eGFP line which produces eGFP in dopaminergic neurons; however,
comparison to online anatomical resources appeared to support the identity of the
structure being DC7. Although there was uncertainty surrounding the hypothalamic
cluster selected for this study, the justifications for selecting this region were that it is a
bright, distinct, and consistently identifiable structure in the ventral end of the
hypothalamus. Future studies could use dopamine neuron-specific expression of
GCaMP, for example by making GCaMP expression conditional on expression of the
tyrosine hydroxylase enzyme, to be more certain of the dopaminergic identity of imaged
cells.
In addition to the problems with the hypothalamic region selection, there were
small discrepancies in the medulla region selections which are worth noting. The
variability of pigmentation on the skin above the medulla posed the problem of selecting
the same segment between subjects. As a result, there were small differences in the
region selected on both the anterior-posterior and dorsal-ventral axis. This variability
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may not have been reflected in the standard deviations of medulla measurements, which
appeared similar to the standard deviations of the hypothalamus measurements. This
problem could have been controlled for by raising larvae in 0.003% N-phenylthiourea
(PTU) embryo water solution to inhibit the onset of pigment formation (melanogenesis),
which was done in another study examining neuronal activity in the Elavl3:GCaMP line
(Turrini et al., 2017).
The last important limitation of this study which should be mentioned is the
removal of one of the originally proposed hypotheses. The literature review of this study
includes a section on larval neurogenesis because I had intended to test whether there was
an increase in neuron count in the hypothalamus at 6dpf due to the 0.1µM BPA exposure
dose used in the other hypotheses. Both time constraints and the inability to implement
defensible methods led to the abandoning of this hypothesis, which had not been central
to the main goal of the study.

Directions for Future Research
This study is believed to be the first of its kind in using the Elavl3:GCaMP line to
analyze Ca2+ activity in the larval zebrafish brain after BPA exposure. Due to the
inconclusive results of this study, questions remain about whether BPA may affect Ca2+
activity, how varying doses may elicit different responses, and if Ca2+ dynamics can be
correlated or otherwise causally connected to observed swim activity changes. There
appear to be few literature search results for both the Elavl3:GCaMP zebrafish line as
well as BPA’s effect on swim behavior, so it could be that designing a study that
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attempted to link early-stage research in these areas was overly ambitious in the context
of a graduate student’s thesis project. Although the project was not fruitful in terms of
confirming hypotheses by finding significant results, there was progress made in laying
out the theoretical and methodological groundwork for potential future studies seeking to
test related concepts. A good direction for future research may be to further justify the
theoretical relationship between BPA and Ca2+, to narrow down the focus to specific
brain regions that have been demonstrated to exhibit circuitry related to motor behavior,
and lastly to attempt a range of doses that may elicit an effect on Ca2+ dynamics and
swim activity in either direction rather than just one.
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Conclusions, Summary or Recommendations

The pervasiveness of endocrine disrupting chemicals in modern society presents a
continuous hazard to public health in both humans and wildlife alike. Xenoestrogens
have been a focal point of research in this area due to their tendency to leech from
plastics that humans commonly interact with. The effects of BPA exposure have been
correlated to sexual dysfunction, fertility problems, obesity, type-2 diabetes,
cardiovascular disease, neurobehavioral deficits in children, and many other deleterious
effects in humans (Rochester, 2013). The perinatal and childhood development windows
represent a critical period of vulnerability to the disrupting biological effects of exposure,
which can result in adverse long-term effects.

Zebrafish have become a lead model

organism in toxicology research, with zebrafish embryo toxicity testing showing promise
in the ability to accurately predict relative acute toxicity in mammals (Ducharme, Reif,
Gustafsson, & Bondesson, 2015). Furthermore, the ability to develop transgenic lines
that allow in vivo observation of specific biological responses to chemical exposures
offers a distinct advantage over mammalian testing. The Cyp19a1b:GFP zebrafish line
was developed to act as a sensitive tool which can measure estrogen-activating effects in
the brain with remarkable specificity to neural progenitor cells. This line can be used to
detail complex relationships between estrogenic activity in the brain and a wide variety of
adverse effects both biological and behavioral, especially when used in conjunction with
lines such as Elavl3:GCaMP or using other targeted methodologies.
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Although the current study’s attempt to draw connections between estrogenic
activity, calcium dynamics, and behavior using transgenic zebrafish lines was unable to
determine any relationships between them, the fact that it was able to be tried at all shows
the remarkable potential that these lines offer to researchers.
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Appendix A: Cyp19a1b:GFP Experiment R Script

#Cyp19a1b:GFP dataset
> Cyp19_dataset <- read_excel("C:/Users/Ryan/Desktop/Cyp19
dataset.xlsx")
> View(Cyp19_dataset)
> Cyp19_dataset$Group<-factor(Cyp19_dataset$Group, levels = c(1:4))
> levels(Cyp19_dataset$Group)[1]<-"BPA 0.1"
> levels(Cyp19_dataset$Group)[2]<-"CTRL 0.1"
> levels(Cyp19_dataset$Group)[3]<-"BPA 2.5"
> levels(Cyp19_dataset$Group)[4]<-"CTRL 2.5"
#Descriptive Statistics
> summary(Cyp19_dataset)
Group
ROI mean
Baseline
Pixel Value
BPA 0.1 :15
Min.
:301.6
Min.
:254.2
Min.
:
CTRL 0.1:15
1st Qu.:442.5
1st Qu.:309.1
1st Qu.:
BPA 2.5 : 6
Median :570.8
Median :510.1
Median :
CTRL 2.5: 6
Mean
:522.0
Mean
:451.1
Mean
:
3rd Qu.:588.5
3rd Qu.:525.9
3rd Qu.: 82.79
Max.
:643.7
Max.
:559.2
Max.
:207.35

24.82
45.44
59.01
70.85

> tapply(Cyp19_dataset$`ROI mean`, Cyp19_dataset$Group, mean)
BPA 0.1 CTRL 0.1 BPA 2.5 CTRL 2.5
585.5105 582.0549 417.5735 317.5218
> tapply(Cyp19_dataset$`ROI mean`, Cyp19_dataset$Group, sd)
BPA 0.1 CTRL 0.1 BPA 2.5 CTRL 2.5
18.32439 25.69854 36.62011 24.62259
> tapply(Cyp19_dataset$`ROI mean`, Cyp19_dataset$Group, var)
BPA 0.1 CTRL 0.1
BPA 2.5 CTRL 2.5
335.7834 660.4150 1341.0324 606.2718
> tapply(Cyp19_dataset$Baseline, Cyp19_dataset$Group, mean)
BPA 0.1 CTRL 0.1 BPA 2.5 CTRL 2.5
524.0372 521.7891 269.5913 273.8767
> tapply(Cyp19_dataset$Baseline, Cyp19_dataset$Group, sd)
BPA 0.1 CTRL 0.1 BPA 2.5 CTRL 2.5
19.03797 15.57455 19.40222 26.33961
> tapply(Cyp19_dataset$Baseline, Cyp19_dataset$Group, var)
BPA 0.1 CTRL 0.1 BPA 2.5 CTRL 2.5
362.4443 242.5665 376.4461 693.7750
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#Descriptives continued
> tapply(Cyp19_dataset$`Pixel Value`, Cyp19_dataset$Group, mean)
BPA 0.1 CTRL 0.1
BPA 2.5 CTRL 2.5
61.47333 60.26573 147.98217 43.64517
> tapply(Cyp19_dataset$`Pixel Value`, Cyp19_dataset$Group, sd)
BPA 0.1 CTRL 0.1
BPA 2.5 CTRL 2.5
21.828533 15.064232 32.795375 9.948652
> tapply(Cyp19_dataset$`Pixel Value`, Cyp19_dataset$Group, var)
BPA 0.1
CTRL 0.1
BPA 2.5
CTRL 2.5
476.48487 226.93108 1075.53664
98.97568
#Experiment 1 data subset & T-test
> Cyp19_Experiment_1<-Cyp19_dataset[(Cyp19_dataset$Group=="BPA
0.1"|Cyp19_dataset$Group=="CTRL 0.1"),]
> View(Cyp19_Experiment_1)
> t.test(Cyp19_Experiment_1$`Pixel Value`~Cyp19_Experiment_1$Group,
var.equal=TRUE)
Two Sample t-test
data: Cyp19_Experiment_1$`Pixel Value` by Cyp19_Experiment_1$Group
t = 0.17634, df = 28, p-value = 0.8613
alternative hypothesis: true difference in means is not equal to 0
95 percent confidence interval:
-12.81979 15.23499
sample estimates:
mean in group BPA 0.1 mean in group CTRL 0.1
61.47333
60.26573
#Experiment 1 effect size
> library(lsr)
> Cyp19_Experiment_1$Group<-factor(Cyp19_Experiment_1$Group)
> levels(Cyp19_Experiment_1$Group)
[1] "BPA 0.1" "CTRL 0.1"
> cohensD(Cyp19_Experiment_1$`Pixel Value`~Cyp19_Experiment_1$Group)
[1] 0.06439201
#Experiment 2 data subset & T-test
> Cyp19_Experiment_2<-Cyp19_dataset[(Cyp19_dataset$Group=="BPA
2.5"|Cyp19_dataset$Group=="CTRL 2.5"),]
> View(Cyp19_Experiment_2)
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> t.test(Cyp19_Experiment_2$`Pixel Value`~Cyp19_Experiment_2$Group,
var.equal=FALSE)
Welch Two Sample t-test
data: Cyp19_Experiment_2$`Pixel Value` by Cyp19_Experiment_2$Group
t = 7.4574, df = 5.9125, p-value = 0.0003211
alternative hypothesis: true difference in means is not equal to 0
95 percent confidence interval:
69.97874 138.69526
sample estimates:
mean in group BPA 2.5 mean in group CTRL 2.5
147.98217
43.64517
#Experiment 2 effect size
> library(lsr)
> Cyp19_Experiment_2$Group<-factor(Cyp19_Experiment_2$Group)
> levels(Cyp19_Experiment_2$Group)
[1] "BPA 2.5" "CTRL 2.5"
> cohensD(Cyp19_Experiment_2$`Pixel Value`~Cyp19_Experiment_2$Group)
[1] 4.30551
#ANOVA & Tukey Test
> View(Cyp19_dataset_2_0)
> Cyp19_dataset_2_0$Group<-factor(Cyp19_dataset_2_0$Group, levels =
c(1:4))
> levels(Cyp19_dataset_2_0$Group)[1]<-"BPA 0.1"
> levels(Cyp19_dataset_2_0$Group)[2]<-"CTRL 0.1"
> levels(Cyp19_dataset_2_0$Group)[3]<-"BPA 2.5"
> levels(Cyp19_dataset_2_0$Group)[4]<-"CTRL 2.5"
> ANOVA<-aov(Pixel_Value~Group, Cyp19_dataset_2_0)
> summary(ANOVA)
Df Sum Sq Mean Sq F value
Pr(>F)
Group
3 43136
14379
34.76 5.54e-11 ***
Residuals
38 15720
414
--Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
> etaSquared(ANOVA)
eta.sq eta.sq.part
Group 0.732903
0.732903
> TUKEY<-glht(ANOVA,linfct=mcp(Group="Tukey"))
> summary(TUKEY)
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Simultaneous Tests for General Linear Hypotheses
Multiple Comparisons of Means: Tukey Contrasts
Fit: aov(formula = Pixel_Value ~ Group, data = Cyp19_dataset_2_0)
Linear Hypotheses:
Estimate Std. Error t value
CTRL 0.1 - BPA 0.1 == 0
-1.208
7.427 -0.163
BPA 2.5 - BPA 0.1 == 0
86.509
9.825
8.805
CTRL 2.5 - BPA 0.1 == 0
-17.828
9.825 -1.815
BPA 2.5 - CTRL 0.1 == 0
87.716
9.825
8.928
CTRL 2.5 - CTRL 0.1 == 0 -16.621
9.825 -1.692
CTRL 2.5 - BPA 2.5 == 0 -104.337
11.743 -8.885

Pr(>|t|)
0.998
<0.001 ***
0.277
<0.001 ***
0.337
<0.001 ***
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Appendix B: Elavl3:GCaMP Experiment R Script

#Elavl3:GCaMP dataset
> GCaMP_dataset <- read_excel("C:/Users/Ryan/Desktop/GCaMP
dataset.xlsx")
> View(GCaMP_dataset)
> GCaMP_dataset$Group<-factor(GCaMP_dataset$Group, levels = c(1:2))
> summary(GCaMP_dataset$Group)
1 2
28 29
> levels(GCaMP_dataset$Group)[1]<-"BPA"
> levels(GCaMP_dataset$Group)[2]<-"CTRL"
> summary(GCaMP_dataset$Group)
BPA CTRL
28
29
#Descriptive Statistics
> summary(GCaMP_dataset)
Group
Hypothalamus
Medulla
Hyp/Med
BPA :28
Min.
: 4.902
Min.
: 53.55
Min.
:0.06988
CTRL:29
1st Qu.:28.540
1st Qu.:113.17
1st Qu.:0.18584
Median :43.135
Median :173.01
Median :0.26288
Mean
:44.877
Mean
:172.23
Mean
:0.27704
3rd Qu.:58.140
3rd Qu.:209.78
3rd Qu.:0.34671
Max.
:86.859
Max.
:376.51
Max.
:0.56667
> tapply(GCaMP_dataset$Hypothalamus, GCaMP_dataset$Group, mean)
BPA
CTRL
48.25411 41.61552
> tapply(GCaMP_dataset$Hypothalamus, GCaMP_dataset$Group, sd)
BPA
CTRL
18.05838 22.88510
> tapply(GCaMP_dataset$Hypothalamus, GCaMP_dataset$Group, var)
BPA
CTRL
326.1049 523.7279
> tapply(GCaMP_dataset$Medulla, GCaMP_dataset$Group, mean)
BPA
CTRL
179.2896 165.4091
> tapply(GCaMP_dataset$Medulla, GCaMP_dataset$Group, sd)
BPA
CTRL
58.56215 81.70477
> tapply(GCaMP_dataset$Medulla, GCaMP_dataset$Group, var)
BPA
CTRL
3429.526 6675.669
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> tapply(GCaMP_dataset$`Hyp/Med`, GCaMP_dataset$Group, mean)
BPA
CTRL
0.2834334 0.2708623
> tapply(GCaMP_dataset$`Hyp/Med`, GCaMP_dataset$Group, sd)
BPA
CTRL
0.1042215 0.1296929
> tapply(GCaMP_dataset$`Hyp/Med`, GCaMP_dataset$Group, var)
BPA
CTRL
0.01086213 0.01682025
#Independent Samples t-tests
> t.test(GCaMP_dataset$Hypothalamus~GCaMP_dataset$Group,
var.equal=TRUE)
Two Sample t-test
data: GCaMP_dataset$Hypothalamus by GCaMP_dataset$Group
t = 1.213, df = 55, p-value = 0.2303
alternative hypothesis: true difference in means is not equal to 0
95 percent confidence interval:
-4.329595 17.606775
sample estimates:
mean in group BPA mean in group CTRL
48.25411
41.61552
> t.test(GCaMP_dataset$Medulla~GCaMP_dataset$Group, var.equal=TRUE)
Two Sample t-test
data: GCaMP_dataset$Medulla by GCaMP_dataset$Group
t = 0.73489, df = 55, p-value = 0.4655
alternative hypothesis: true difference in means is not equal to 0
95 percent confidence interval:
-23.97153 51.73246
sample estimates:
mean in group BPA mean in group CTRL
179.2896
165.4091
> t.test(GCaMP_dataset$`Hyp/Med`~GCaMP_dataset$Group,
var.equal=TRUE)
Two Sample t-test
data: GCaMP_dataset$`Hyp/Med` by GCaMP_dataset$Group
t = 0.40251, df = 55, p-value = 0.6889
alternative hypothesis: true difference in means is not equal to 0
95 percent confidence interval:
-0.05001844 0.07516063
sample estimates:
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mean in group BPA mean in group CTRL
0.2834334
0.2708623
#Effect Sizes
> library(lsr)
> cohensD(GCaMP_dataset$Hypothalamus~GCaMP_dataset$Group)
[1] 0.3213719
> cohensD(GCaMP_dataset$Medulla~GCaMP_dataset$Group)
[1] 0.1947073
> cohensD(GCaMP_dataset$`Hyp/Med`~GCaMP_dataset$Group)
[1] 0.1066444
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Appendix C: Behavior Experiment R Script

#Behavior dataset
> Behavior_dataset <- read_excel("C:/Users/Ryan/Desktop/Behavior
dataset.xlsx")
> View(Behavior_dataset)
> Behavior_dataset$Group<-factor(Behavior_dataset$Group, levels =
c(1:2))
> levels(Behavior_dataset$Group)[1]<-"BPA"
> levels(Behavior_dataset$Group)[2]<-"CTRL"
#Descriptive Statistics
> tapply(Behavior_dataset$`Light Off`, Behavior_dataset$Group, mean)
BPA
CTRL
29.65790 29.60635
> tapply(Behavior_dataset$`Light Off`, Behavior_dataset$Group, sd)
BPA
CTRL
9.159700 7.510379
> tapply(Behavior_dataset$`Light Off`, Behavior_dataset$Group, var)
BPA
CTRL
83.90010 56.40579
> summary(Behavior_dataset)
Group
Light Off
Light On
BPA :73
Min.
: 5.549
Min.
: 0.03976
CTRL:73
1st Qu.:23.047
1st Qu.: 1.10664
Median :28.636
Median : 8.89963
Mean
:29.632
Mean
:12.80158
3rd Qu.:35.606
3rd Qu.:21.86957
Max.
:55.915
Max.
:51.45969
NA's
:26
#Independent Samples T-test
> t.test(Behavior_dataset$`Light Off`~Behavior_dataset$Group,
var.equal=TRUE)
Two Sample t-test
data: Behavior_dataset$`Light Off` by Behavior_dataset$Group
t = 0.037184, df = 144, p-value = 0.9704
alternative hypothesis: true difference in means is not equal to 0
95 percent confidence interval:
-2.688698 2.791797
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sample estimates:
mean in group BPA mean in group CTRL
29.65790
29.60635
#Effect Size
> library(lsr)
> cohensD(Behavior_dataset$`Light Off`~Behavior_dataset$Group)
[1] 0.006154658
#Descriptive Statistics continued
#Omitted NA values for 'Light On''
> Behavior_Omit_NA<-na.omit(Behavior_dataset[-2])
> View(Behavior_Omit_NA)
> summary(Behavior_Omit_NA)
Group
Light On
BPA :62
Min.
: 0.03976
CTRL:58
1st Qu.: 1.10664
Median : 8.89963
Mean
:12.80158
3rd Qu.:21.86957
Max.
:51.45969
> tapply(Behavior_Omit_NA$`Light
BPA
CTRL
12.68109 12.93038
> tapply(Behavior_Omit_NA$`Light
BPA
CTRL
12.36014 12.37762
> tapply(Behavior_Omit_NA$`Light
BPA
CTRL
152.7730 153.2054
> t.test(Behavior_Omit_NA$`Light
var.equal=TRUE)

On`, Behavior_Omit_NA$Group, mean)
On`, Behavior_Omit_NA$Group, sd)
On`, Behavior_Omit_NA$Group, var)
On`~Behavior_Omit_NA$Group,

#Independent Samples T-tests continued
> t.test(Behavior_Omit_NA$`Light On`~Behavior_Omit_NA$Group,
var.equal=TRUE)
Two Sample t-test
data: Behavior_Omit_NA$`Light On` by Behavior_Omit_NA$Group
t = -0.11033, df = 118, p-value = 0.9123
alternative hypothesis: true difference in means is not equal to 0
95 percent confidence interval:
-4.723597 4.225014
sample estimates:
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mean in group BPA mean in group CTRL
12.68109
12.93038
#Effect Size
> library(lsr)
> cohensD(Behavior_Omit_NA$`Light On`~Behavior_Omit_NA$Group)
[1] 0.02015522
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Appendix D: Chemical Data Table, Structures, and Safety Information

Chemical Data Table

Chemical Name

Molar
Mass
(g/mol)
228.291

Melting
point

Boiling
point

(°C)

(°C)

158-159

220

1.20

Dimethyl Sulfoxide

78.13

19

189

1.1004

Tricaine
methanesulfonate

261.292

147-150

N/A

N/A

Bisphenol A
(4,4'isopropylidenediphenol)

Density

Hazards

(g/ cm3)

Danger:
Allergic skin
reaction,
serious eye
damage,
respiratory
irritation,
reproductive
toxicity,
flammable
Warning:
Skin
irritation, eye
irritation,
respiratory
irritation,
flammable
Warning:
Skin
irritation, eye
irritation,
respiratory
irritation,
anesthetic
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BPA Safety Information
Hazards.
Air & Water Reactions – The finely powdered resin is a significant dust explosion
hazard. Insoluble in water.
Fire Hazard –. The chemical is combustible and may form explosive dust clouds. Static
electricity can cause its dust to explode.
Health Hazard – Dusts irritating to upper respiratory passages; may cause sneezing.
Reactivity Profile – 4,4'-isopropylidenediphenol is incompatible with strong oxidizers. It
is also incompatible with strong bases, acid chlorides and acid anhydrides.
Belongs to the Following Reactive Group(s) – Phenols and Cresols
First Aid.
EYES – Check if victim is wearing contact lenses and remove if present. Flush eyes with
water or normal saline solution for 20-30 minutes while calling a hospital or poison
control center, do not apply medication into eyes without specific instructions from a
physician. IMMEDIATELY transport victim to hospital even if no symptoms are visible.
SKIN – IMMEDIATELY flood affected skin with water while removing and isolating all
contaminated clothing. Gently wash all affected skin areas thoroughly with soap and
water. If symptoms such as redness or irritation develop call a physician immediately.
INHALATION – IMMEDIATELY leave the contaminated area: take deep breaths of
fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in
the mouth, throat, or chest develop) call a physician and be prepared to transport the
victim to a hospital. Provide proper respiratory protection to rescuers entering an
unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA)
should be used; if not available, use a level of protection greater than or equal to that
advised under Protective Clothing.
INGESTION – DO NOT INDUCE VOMITING. If the victim is conscious and not
convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call
a hospital or poison control center. Be prepared to transport the victim to a hospital if
advised by a physician. If the victim is convulsing or unconscious, do not give anything
by mouth, ensure that the victim's airway is open and lay the victim on his/her side with
the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY
transport the victim to a hospital.

TEST OF BPA’S ESTROGENIC EFFECTS IN ZEBRAFISH

83

Response Recommendations.
Isolation and Evacuation - As an immediate precautionary measure, isolate spill or leak
area for at least 50 meters (150 feet) in all directions.
SPILL: Increase, in the downwind direction, as necessary, the isolation distance shown
above.
FIRE: If tank, rail car or tank truck is involved in a fire, ISOLATE for 800 meters (1/2
mile) in all directions; also, consider initial evacuation for 800 meters (1/2 mile) in all
directions.
Firefighting – Fire Extinguishing Agents: Foam, dry chemical, carbon dioxide
Non-fire Response – SMALL SPILLS AND LEAKAGE: Should a spill occur while you
are handling this chemical, FIRST REMOVE ALL SOURCES OF IGNITION, then you
should dampen the solid spill material with 60-70% ethanol and transfer the dampened
material to a suitable container. Use absorbent paper dampened with 60-70% ethanol to
pick up any remaining material. Seal the absorbent paper, and any of your clothes, which
may be contaminated, in a vapor-tight plastic bag for eventual disposal. Solvent wash all
contaminated surfaces with 60-70% ethanol followed by washing with a soap and water
solution. Do not reenter the contaminated area until the Safety Officer (or other
responsible person) has verified that the area has been properly cleaned.
STORAGE PRECAUTIONS: You should store this chemical under ambient conditions
and keep it away from oxidizing materials.
Protective Clothing - Approved dust mask and clean, body-covering clothing sufficient to
prevent excessive or repeated exposure to dust, fumes, or solutions. Safety glasses with
side shields.

Safety information derived from CAMEO Chemicals:
https://cameochemicals.noaa.gov/chemical/8331

